Interactions between Social/ behavioral factors and ADRB2 genotypes may be associated with health at advanced ages in China

BMC Geriatrics

Elizabeth R Hauser^1,12  Xiao-Li Tian³  Wei Tao¹  Jun Gu¹  Ze Yang²  Simon G Gregory^1,12  Huiqing Cao³  Fengyu Zhang⁴  Jianxin Li⁹  Ke Shen⁵  Huashuai Chen⁶  Qiushi Feng^1,11  Qihua Tan⁷  Ling Zhao³  Lingguo Cheng⁸  Yi Zeng^1,10 

[1] School of Life Sciences, Peking University, Beijing, China;National Institute of Geriatrics, Beijing Hospital, Ministry of Health of China, Beijing, China;Department of Human Population Genetics, Institute of Molecular Medicine, Peking University, Beijing, China;Gene, Cognition and Psychosis Program, National Institute of Mental Health and Lieber Institute for Brain Development, Baltimore, MD, USA;Institute of Population Research, Fudan University, Shanghai, China;Business School, Xiang Tan University, Xiangtan, China;Institute of Public Health, University of Southern Denmark, Odense, Denmark;School of Business, Nanjing University, Nanjing, China;Department of Sociology, Peking University, Beijing, China;Center for Healthy Aging and Development Studies, Duke University and National School of Development, Peking University, Beijing, China;Department of Sociology, National University of Singapore, Singapore, Singapore;Center for Human Genetics, Medical School, Duke University, Durham, NC, USA

关键词: Negative emotion;    Social-leisure activities;    Regular exercise;    Self-reported health;    Cognitive function;    GxE Interactions;    ADRB2 genotypes;    Social/behavioral factors;    Oldest-old;    Health aging;   

Others  :  856852
DOI  :  10.1186/1471-2318-13-91

 received in 2013-02-20, accepted in 2013-08-05,  发布年份 2013

【 摘 要 】

Background

Existing literature indicates that ADRB2 gene is associated with health and longevity, but none of previous studies investigated associations of carrying the ADRB2 minor alleles and interactions between ADRB2 genotypes and social/behavioral factors(GxE) with health outcomes at advanced ages. This study intends to fill in this research gap.

Method

We conducted an exploratory analysis, using longitudinal survey phenotype/genotype data from 877 oldest-old aged 90+. To estimate association of GxE interactions with health outcome, adjusted for the potential correlation between genotypes and social/behavioral factors and various other potentially confounding factors, we develop and test an innovative three-step procedure which combines logistic regression and structural equation methods.

Results

Interaction between regular exercise and carrying rs1042718 minor allele is significantly and positively associated with good cognitive function; interaction between regular exercise and carrying rs1042718 or rs1042719 minor allele is significantly and positively associated with self-reported good health; and interaction between social-leisure activities and carrying rs1042719 minor allele is significantly and positively associated with self-reported good health. Carrying rs1042718 or rs1042719 minor alleles is significantly and negatively associated with negative emotion, but the ADRB2 SNPs are not significantly associated with cognitive function and self-reported health. Our structural equation analysis found that, adjusted for the confounding effects of correlation of the ADRB2 SNPs with negative emotion, interaction between negative emotion and carrying rs1042718 or rs1042719 minor allele is significantly and negatively associated with cognitive function. The positive association of regular exercise and social-leisure activities with cognitive function and self-reported health, and negative association of negative emotion with cognitive function, were much stronger among carriers of rs1042718 or rs1042719 alleles, compared to the non-carriers.

Conclusions

The results indicate significant positive associations of interactions between social/behavioral factors and the ADRB2 genotypes with health outcomes of cognitive function and self-reported health, and negative associations of carrying rs1042718 or rs1042719 minor alleles with negative emotion, at advanced ages in China. Our findings are exploratory rather than causal conclusions. This study implies that near-future health promotion programs considering individuals’ genetic profiles, with appropriate protection of privacy/confidentiality, would yield increased benefits and reduced costs to the programs and their participants.

【 授权许可】

   
2013 Zeng et al.; licensee BioMed Central Ltd.

【 图 表 】

【 参考文献 】

• [1]Chang L, Villacorta L, Zhang J, Garcia-Barrio MT, Yang K, Hamblin M, Whitesall SE, D’Alecy LG, Chen YE: Vascular smooth muscle cell–selective peroxisome proliferator–activated receptor-γ deletion leads to hypotension. Circulation 2009, 119(16):2161-2169.
• [2]Singh M, Roginskaya M, Dalal S, Menon B, Kaverina E, Boluyt MO, Singh K: Extracellular ubiquitin inhibits beta-AR-stimulated apoptosis in cardiac myocytes: role of GSK-3beta and mitochondrial pathways. Cardiovasc Res 2010, 86(1):20-28.
• [3]Zee RY, Cook NR, Cheng S, Erlich HA, Lindpaintner K, Ridker PM: Polymorphism in the beta2-adrenergic receptor and lipoprotein lipase genes as risk determinants for idiopathic venous thromboembolism: a multilocus, population-based, prospective genetic analysis. Circulation 2006, 113(18):2193-2200.
• [4]Woszczek G, Borowiec M, Ptasinska A, Kosinski S, Pawliczak R, Kowalski M: β2‒ADR haplotypes/polymorphisms associate with bronchodilator response and total IgE in grass allergy. Allergy 2005, 60(11):1412-1417.
• [5]Yan L, Vatner DE, O’Connor JP, Ivessa A, Ge H, Chen W, Hirotani S, Ishikawa Y, Sadoshima J, Vatner SF: Type 5 adenylyl cyclase disruption increases longevity and protects against stress. Cell 2007, 130(2):247-258.
• [6]Kulminski AM, Culminskaya I, Ukraintseva SV, Arbeev KG, Land KC, Yashin AI: Beta2-adrenergic receptor gene polymorphisms as systemic determinants of healthy aging in an evolutionary context. Mech Ageing Dev 2010, 131(5):338-345.
• [7]Kulminski AM, Culminskaya IV, Ukraintseva SV, Arbeev KG, Akushevich I, Land KC, Yashin AI: Polymorphisms in the ACE and ADRB2 genes and risks of aging-associated phenotypes: the case of myocardial infarction. Rejuvenation Res 2010, 13(1):13-21.
• [8]Zhao L, Yang F, Xu K, Cao H, Zheng GY, Zhang Y, Li J, Cui H, Chen X, Zhu Z, et al.: Common genetic variants of the beta2-adrenergic receptor affect its translational efficiency and are associated with human longevity. Aging Cell 2012, 11(6):1094-1101.
• [9]Maddock RJ, Carter CS, Magliozzi JR, Gietzen D: Evidence that decreased function of lymphocyte beta adrenoreceptors reflects regulatory and adaptive processes in panic disorder with agoraphobia. Am J Psychiatry 1993, 150(8):1219.
• [10]Suarez EC, Shiller AD, Kuhn CM, Schanberg S, Williams R, Zimmermann EA: The relationship between hostility and beta-adrenergic receptor physiology in health young males. Psychosom Med 1997, 59(5):481-487.
• [11]Mann JJ, Brown RP, Halper JP, Sweeney JA, Kocsis JH, Stokes PE, Bilezikian JP: Reduced sensitivity of lymphocyte beta-adrenergic receptors in patients with endogenous depression and psychomotor agitation. New Engl J Med 1985, 313(12):715-720.
• [12]Yu BH, Dimsdale JE, Mills PJ: Psychological states and lymphocyte β-adrenergic receptor responsiveness. Neuropsychopharmacology 1999, 21(1):147-152.
• [13]Magliozzi JR, Gietzen D, Maddock RJ, Haack D, Doran AR, Goodman T, Weiler PG: Lymphocyte beta-adrenoreceptor density in patients with unipolar depression and normal controls. Biol Psychiat 1989, 26(1):15-25.
• [14]Connors SL, Crowell DE, Eberhart CG, Copeland J, Newschaffer CJ, Spence SJ, Zimmerman AW: β 2-Adrenergic receptor activation and genetic polymorphisms in autism: data from dizygotic twins. J Child Neurol 2005, 20(11):876-884.
• [15]Cheslack-Postava K, Fallin M, Avramopoulos D, Connors S, Zimmerman A, Eberhart C, Newschaffer C: β2-Adrenergic receptor gene variants and risk for autism in the AGRE cohort. Mol Psychiatr 2007, 12(3):283-291.
• [16]Wang D, Govindaiah G, Liu R, De Arcangelis V, Cox CL, Xiang YK: Binding of amyloid β peptide to β2 adrenergic receptor induces PKA-dependent AMPA receptor hyperactivity. FASEB J 2010, 24(9):3511-3521.
• [17]Yu JT, Tan L, Ou JR, Zhu JX, Liu K, Song JH, Sun YP: Polymorphisms at the β2-adrenergic receptor gene influence Alzheimer’s disease susceptibility. Brain Res 2008, 1210:216-222.
• [18]Dimsdale JE, Mills P, Patterson T, Ziegler M, Dillon E: Effects of chronic stress on beta-adrenergic receptors in the homeless. Psychosom Med 1994, 56(4):290-295.
• [19]Diatchenko L, Anderson AD, Slade GD, Fillingim RB, Shabalina SA, Higgins TJ, Sama S, Belfer I, Goldman D, Max MB: Three major haplotypes of the β2 adrenergic receptor define psychological profile, blood pressure, and the risk for development of a common musculoskeletal pain disorder. Am J Med Genet B Neuropsychiatr Genet 2006, 141(5):449-462.
• [20]Graafsma SJ, van Tits LJ, van Heijst P, Reyenga J, Lenders JWM, de Miranda JFR, Thien T: Adrenoceptors on blood cells in patients with essential hypertension before and after mental stress. J Hypertens 1989, 7(7):519-524.
• [21]Lanfear DE, Jones PG, Marsh S, Cresci S, McLeod HL, Spertus JA: β2-adrenergic receptor genotype and survival among patients receiving β-blocker therapy after an acute coronary syndrome. JAMA 2005, 294(12):1526-1533.
• [22]Lanfear DE, Spertus JA, McLeod HL: [beta] 2-adrenergic receptor genotype predicts survival: implications and future directions. J Cardiovasc Nursing 2006, 21(6):474-477.
• [23]Ferdinands JM, Mannino DM, Gwinn ML, Bray MS: ADRB2 Arg16Gly polymorphism, lung function, and mortality: results from the atherosclerosis risk in communities study. PloS one 2007, 2(3):e289.
• [24]Landi MT, Dracheva T, Rotunno M, Figueroa JD, Liu H, Dasgupta A, Mann FE, Fukuoka J, Hames M, Bergen AW: Gene expression signature of cigarette smoking and its role in lung adenocarcinoma development and survival. PLoS One 2008, 3(2):e1651.
• [25]Sehnert AJ, Daniels SE, Elashoff M, Wingrove JA, Burrow CR, Horne B, Muhlestein JB, Donahue M, Liggett SB, Anderson JL, et al.: Lack of association between adrenergic receptor genotypes and survival in heart failure patients treated with carvedilol or metoprolol. J Am Coll Cardiol 2008, 52(8):644-651.
• [26]Nakada T, Russell JA, Boyd JH, Aguirre-Hernandez R, Thain KR, Thair SA, Nakada E, McConechy M, Walley KR: β2-adrenergic receptor gene polymorphism is associated with mortality in septic shock. Am J Resp Crit Care 2010, 181(2):143-149.
• [27]Hjelmborg JB, Iachine I, Skytthe A, Vaupel JW, McGue M, Koskenvuo M, Kaprio J, Pedersen NL, Christensen K: Genetic influence on human lifespan and longevity. Human Genetics 2006, 119(3):312-321.
• [28]Ewbank DC: Mortality Differences by APOE Genotype Estimated From Demographic Synthesis. Genet Epidemiol 2002, 22:146-155.
• [29]Zeng Y, Poston DL Jr, Vlosky DA, Gu D: Healthy longevity in China: demographic, socioeconomic, and psychological dimensions, Volume 20. Dordrecht, the Netherlands: Springer Publisher; 2008.
• [30]Zeng Y, Vaupel JW: Functional capacity and self–evaluation of health and life of oldest old in China. J Social Issues 2002, 58(4):733-748.
• [31]Coale AJ, Li S: The effect of age misreporting in China on the calculation of mortality rates at very high ages. Demography 1991, 28(2):293-301.
• [32]Wang Z, Zeng Y, Jeune B, Vaupel JW: Age validation of Han Chinese centenarians. Genus 1998, 54(1/2):123-141.
• [33]Poston DL, Luo H: Zhongguo 2000 nian shaoshu minzu de nian ling dui ji he shu zi pian hao (Age structure and composition of the Chinese minorities in 2000). Zhongguo Shaoshu Minzu Renkou (Chinese Minority Populations) 2004, 19(3):9-15.
• [34]Folstein MF, Folstein SE, McHugh PR: “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975, 12(3):189-198.
• [35]Deb S, Braganza J: Comparison of rating scales for the diagnosis of dementia in adults with Down’s syndrome. J Intellect Disabil Res 1999, 43(5):400-407.
• [36]Osterweil D, Mulford P, Syndulko K, Martin M: Cognitive function in old and very old residents of a residential facility: Relationship to age, education, and dementia. J Am Geriatr Soc 1994, 42(7):766-773.
• [37]Power C, Matthews S, Manor O: Inequalities in self-rated health: explanations from different stages of life. Lancet 1998, 351(9108):1009-1013.
• [38]Mackenbach JP, Kunst AE, Cavelaars AEJM, Groenhof F, Geurts JJM, Studygroup A, Gunning-Schepers L: Socioeconomic inequalities in morbidity and mortality in western Europe. Lancet 1997, 349:1655-1659.
• [39]Shetterly SM, Baxter J, Mason LD, Hamman RF: Self-rated health among Hispanic vs non-Hispanic white adults: the San Luis Valley Health and Aging Study. Am J Public Health 1996, 86(12):1798-1801.
• [40]Singh-Manoux A, Guéguen A, Martikainen P, Ferrie J, Marmot M, Shipley M: Self-rated health and mortality: short-and long-term associations in the Whitehall II study. Psychosom Med 2007, 69(2):138-143.
• [41]Goldman N, Lin IF, Weinstein M, Lin YH: Evaluating the quality of self-reports of hypertension and diabetes. J Clin Epidemiol 2003, 56(2):148-154.
• [42]Østbye T, Krause KM, Norton MC, Tschanz JA, Sanders L, Hayden K, Pieper C, Welsh‒Bohmer KA: Ten dimensions of health and their relationships with overall self‒reported health and survival in a predominately religiously active elderly population: the cache county memory study. J Am Geriatr Soc 2005, 54(2):199-209.
• [43]Kaslow NJ, Rehm LP, Siegel AW: Social-cognitive and cognitive correlates of depression in children. J Abnorm Child Psych 1984, 12(4):605-620.
• [44]Zeng Y, Chen H, Shi X, Yin Z, Yang Z, Gu J, Blazer D: Health Consequences of Familial Longevity Influence Among the Chinese Elderly. J Gerontol A Biol Sci Med Sci 2012. doi:10.1093/gerona/gls203.
• [45]IOM (Institute of Medicine NAoSC): Genes, behavior, and the social environment: Moving beyond the nature/nurture debate. Washington, D.C: National Academia of Sciences; 2006.
• [46]Rothman KJ: Epidemiology: An Introduction. New York: Oxford University Press, USA; 2002.
• [47]Zeng Y, Hughes CL, Lewis MA, Li J, Zhang F: Interactions between life stress factors and carrying the APOE4 allele adversely impact self-reported health in old adults. J Gerontol A Biol Sci Med Sci 2011, 66(10):1054-1061.
• [48]Muthén LK, Muthén BO: Mplus: Statistical Analysis with Latent Variables; User’s Guide; [Version 6]. Los Angeles, CA: Muthén & Muthén; 2010.
• [49]Aiken LS, West SG, Reno RR: Multiple regression: testing and interpreting interactions. Newbury Park, CA: Sage Publications, Inc; 1991.
• [50]Helm R, Mark A: Analysis and evaluation of moderator effects in regression models: state of art, alternatives and empirical example. Rev Manag Sci 2012, 6(4):307-332.
• [51]Mi X, Eskridge KM, George V, Wang D: Structural equation modeling of gene–environment interactions in coronary heart disease. Ann Hum Genet 2011, 75(2):255-265.
• [52]Byrne B: Structural equation modeling with LISREL, PRELIS, and SIMPLIS: Basic concepts, applications, and programming. Mahwah, NJ: Lawrence Erlbaum; 1998.
• [53]Sobel ME: Asymptotic confidence intervals for indirect effects in structural equation models. Sociol Methodology 1982, 13:290-312.
• [54]Bollen KA: Total, direct, and indirect effects in structural equation models. Sociol Methodology 1987, 17(1):37-69.
• [55]Hosmer DW, Lemeshow S: Confidence interval estimation of interaction. Epidemiology 1992, 3(5):452-456.
• [56]Carstens ME, Engelbrecht AH, Russell VA, Aalbers C, Gagiano CA, Chalton DO, Talijaard JJF: Beta-adrenoceptors on lymphocytes of patients with major depressive disorder. Psychiatr Res 1987, 20(3):239-248.
• [57]Pandey GN, Janicak PG, Davis JM: Decreased beta-adrenergic receptors in the leukocytes of depressed patients. Psychiatr Res 1987, 22(4):265-273.
• [58]Kahn AJ: Epigenetic and mitochondrial mechanisms in aging and longevity: a report of a meeting of the longevity consortium, Napa, California, October 25–27, 2006. J Gerontol A Biol Sci Med Sci 2007, 62(6):577-582.
• [59]McDonald JH: Handbook of biological statistics, Volume 2. Baltimore, MD: Sparky House Publishing; 2009.
• [60]Motulsky H: Intuitive biostatistics: a nonmathematical guide to statistical thinking. Oxford: Oxford University Press; 2010.
• [61]Bender R, Lange S: Adjusting for multiple testing—when and how? J Clin Epidemiol 2001, 54(4):343-349.